Streetbeat News

Products Services

BIVI

BioVie announced the completion of a funding round aimed at advancing its clinical priorities in Parkinson's Disease, Alzheimer's Disease, and Ascites/Liver Disease. The company is also exploring longevity and aging with partners.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 12:02 pm

ATXI

Avenue Therapeutics announced it will present preclinical data for BAER-101 at the American Society For Experimental Neurotherapeutics 2024 Annual Meeting on March 13. This marks a significant step in the development of BAER-101.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 12:01 pm

ARCT

Arcturus Therapeutics (NASDAQ:ARCT) has seen a variety of analyst ratings over the past three months, with a recent positive shift in sentiment. Four analysts have provided ratings, with the latest 12-month price targets showing an average of $63.25, up 14.31% from the previous $55.33. The company's financial performance has been strong, with significant revenue growth and above-average financial metrics compared to the industry. Arcturus focuses on RNA medicines for rare diseases, with a notable pipeline including LUNAR-OTC, LUNAR-CF, and LUNAR-COV19.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 12:01 pm

BNTX

BioNTech announced it will present clinical data updates for its personalized mRNA-based and targeted oncology candidates at the AACR 2024 conference. This showcases the company's ongoing efforts in advancing its oncology pipeline.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:53 am

MLTX

MoonLake Immunotherapeutics' stock is trading higher following the announcement of positive 24-week data from the ARGO trial in psoriatic arthritis, along with other research and development updates.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:50 am

AUR

DAVA

LPSN

SMSI

SNOW

The article highlights the top 5 oversold tech stocks in March, based on their RSI values being near or below 30, indicating potential undervaluation. These include Smith Micro Software (SMSI), Aurora Innovation (AUR), Snowflake (SNOW), Endava (DAVA), and LivePerson (LPSN), each with recent financial results and stock performance updates.

Portfolio Pulse from Avi Kapoor

March 11, 2024 | 11:50 am

SONN

Sonnet BioTherapeutics' shares surged following the clearance to proceed to Phase 2 for its SON-080 clinical trial after an independent DSMB review.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:47 am

ATNM

Actinium Pharmaceuticals has initiated a strategic program to enhance the production of the medical isotope Actinium-225, utilizing its unique cyclotron-based method. This move aims to capitalize on the growing demand for Actinium-225 in medical treatments.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:46 am

APCX

AppTech Corp. (APCX) has entered into an agreement to offer its FinZeo platform services to a credit union that operates over 2,000 locations. This partnership aims to enhance the credit union's service offerings.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:44 am

CYN

Cyngn has released the first footage of its AI-powered autonomous Motrec Tugger, showcasing the company's advancements in autonomous vehicle technology. This development could signal a significant step forward for Cyngn in the autonomous vehicle market.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:33 am